EAU Research Foundation organizes meeting in Amsterdam highlighting translational research results
On 22 and 23 June 2009, the Prostate Cancer Translational Research in Europe (PCTRE) meeting will be held in the Beurs van Berlage in Amsterdam (NL). Translational research transforms scientific discoveries arising from laboratory, clinical or population studies into clinical applications to reduc...European Society for Pediatric Urology to organize anniversary congress in Amsterdam
European Society for Paediatric Urology to organise anniversary congress in Amsterdam (NL) From May 6 to 9, the European Society for Paediatric Urology (ESPU) is organising its 20th annual congress. This anniversary meeting promises to be a special one, among other things because of its high-qu...Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
LONDON, Nov. 1 /PRNewswire/ -- Chiltern, a leading global clinical research organization is delighted to announce that it will be a sponsor at the Annual Partnerships in Clinical Trials Conference; which will be held November 5th to 8th, 2007 at the Amsterdam RAI International Exhibit and Cong...Wolters Kluwer Health Launches Interactive Platform for Pharmacology Journal Content
...rope, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, bra...Bolli Becomes New Editor-In-Chief of Circulation Research
...rope, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, bra...Polycystic ovarian syndrome: New light on its causes and its effect on brothers
...ons as well as daughters. The two studies were presented to the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam heard today (Tuesday). Associate Professor Michael Davies told a news briefing: "We already know from clinical studies of women with reproductive p...Women with cystic fibrosis can have safe and successful fertility treatment
...lves or their children, according to new research presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam today (Tuesday). Until relatively recently, cystic fibrosis (CF) was a death sentence and most people with the disease died by the time they reache...Reduced ovarian reserve associated with increased risk of trisomic pregnancy
...l Center Groningen (The Netherlands) presented her findings at the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam today (Tuesday). She said: "The results of my study support a relation between trisomic pregnancy and a decreased quantity of eggs available in th...New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
...References: 1. Wex J et al. HP-hMG versus rFSH in a combination of fresh and cryo cycles in IVF: success rates and economic implications ESHRE. amsterdam 2009, abstract number O-103. 2. 2009. Greenhouse Data on file 3. European and Israeli Study Group on Highly Purified Menotropin versus R...Glybera(TM) Shows Long-Term Health Benefits
...on levels in the blood. The disease can result in difficult-to-treat diabetes and is associated with significant morbidity and mortality. About amsterdam Molecular Therapeutics AMT has a unique production platform that circumvents the obstacles that have hindered development of gene therapy techn...AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
... AMSTERDAM, May 28 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene...er to prevent acute porphyric attacks and their complications. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that t...AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly
...eased risk of cardiovascular complications and diabetes. Currently, there exists no effective treatment or cure for this serious disease. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have pre...AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
... AMSTERDAM, October 3 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader i...ase instead of just treating the symptoms. About amsterdam Molecular Therapeutics AMT has a unique gene the...d on the current expectations of the management of amsterdam Molecular Therapeutics only. Undue reliance should...AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
... AMSTERDAM, June 13 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader i...ical trial with AMT-011 according to plan. About amsterdam Molecular Therapeutics AMT has a unique gene the...d on the current expectations of the management of amsterdam Molecular Therapeutics only. Undue reliance should...Scientists discover Amazon river is 11 million years old
...lion years old and took its present shape about 2.4 million years ago. University of Liverpool researchers, in collaboration with the University of amsterdam and Petrobras, the national oil company of Brazil, analysed sedimentary material taken from two boreholes near the mouth of the river to calculate the...New test can detect both genetic and chromosomal abnormalities in embryos
...nown to have cystic fibrosis. They told a news briefing at the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam today (Tuesday) that, as a result, they would be able to offer clinical trials to couples seeking fertility treatment later this year. The research...Single thawed embryo transfer after PGD does not affect pregnancy rates
...iated with these pregnancies. The research was presented at the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam and published online in Europe's leading reproductive medicine journal, Human Reproduction, simultaneously today (Tuesday). Dr Yacoub Khalaf, direc...ICSI or IVF: Babies born from frozen embryos do just as well
...y Professor Gianpiero Palermo who pioneered ICSI in 1992, told the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam today (Monday) that she and her colleagues had looked at all births from frozen embryos, conceived via ICSI or IVF, between 1993 and 2007. Ms Neri ...Female human embryos adjust the balance of X chromosomes before implantation
...rior to implantation in the womb. Ms Ilse van den Berg told the 25th annual meeting of the European Society of Human Reproduction and Embryology in amsterdam today (Monday) that her findings may have implications for the laboratory cultures that embryos are grown in before transfer to a woman's womb during ...Comprehensive cardiogenetic testing for families of sudden unexplained death victims can save lives
...10% of SUD families are being examined for inherited heart conditions. The study is the second report from the registry of families who attended the amsterdam centre's cardiogenetics department because of unexplained sudden death of a relative aged 1-50 years. The scientists intend to continue to report the ...Tips from the American Journal of Pathology
...ase Progression. Am J Pathol 2009, 174: 2073-2085 Treatment for Oxygen Toxicity Dr. Marieke van Zoelen and colleagues at The University of amsterdam have identified a therapeutic target for preventing oxygen toxicity. They present these findings in the June 2009 issue of the American Journal of P...Call for abstracts and registration for the EMBO Meeting 2009
...organized by the European Molecular Biology Organization (EMBO) and held in amsterdam from 29 August to 1 September 2009. The EMBO Meeting 2009 advances the ... participants are expected to come from Europe and worldwide to meet at the amsterdam RAI convention centre from 29 August to 1 September 2009. Sponsored symposi...Tips from the American Journal of Pathology
...ney injury. Am J Pathol 2009, 174: 1154-1159 New Target for Alzheimer's Disease Therapy Researchers at the VU University Medical Center, amsterdam and the University of Amsterdam, The Netherlands discovered that the unfolded protein response contributes to nerve cell death in Alzheimer's Disease....Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting
...der of Ziering Medical and principal investigator on the clinical trial, addressed attendees on July 25th, 2009 during the conference, taking place in amsterdam July 22-26, 2009. HSC is a proprietary formulation of naturally secreted embryonic proteins, growth factors and contains the first naturally...New IVF Software MedITEX to be Presented at the ESHRE Exhibition
...for in vitro fertilisation, MedITEX IVF, at the 25th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) to be held in amsterdam from 28 June to 1 July. The software solution is the only officially approved program in Germany for the documentation and quality assurance of ART an...AMT Starts Preregistration Trial for Glybera(TM)
... AMSTERDAM, May 7 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene...es and is associated with significant morbidity and mortality. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that t...Amsterdam Molecular Therapeutics Reports Full Year Results 2008
...4330; +44(0)20-7108-6233; or +1-866-416-2558. The archived webcast also will be available for replay shortly after the close of the call. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have pre...AMT to Release Full Year 2008 Results on February 24, 2009
...iopharma.com . Please go to the website fifteen minutes prior to the call to register, download and install the necessary audio software. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have pre...AMT CEO Ronald Lorijn Steps Down
... AMSTERDAM, January 22 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene...expects results to be in line with the guidance given earlier. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that t...Amsterdam Molecular Therapeutics Reports Half Year Results 2008
...T AMSTERDAM, August 13 /PRNewswire-FirstCall/ -- amsterdam Molecular Therapeutics (Euronext: AMT), a leader i...eplay shortly after the close of the call. About amsterdam Molecular Therapeutics AMT has a unique gene the...d on the current expectations of the management of amsterdam Molecular Therapeutics only. Undue reliance should...AMT to Release Half Year 2008 Results on August 13, 2008
...//www.amtbiopharma.com . Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software. About amsterdam Molecular Therapeutics AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevente...